Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opiranserin vs fentanyl PCA for PONV after laparoscopic cholecystectomy
KCT0012398Phase 4Not yet recruiting
- Sponsor
- Konyang University Hospital
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of opiranserin and fentanyl in cholecystitis and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Konyang University Hospital. Primary endpoint: Postoperative nausea and vomiting. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
opiranserinfentanyl
03
Conditions
cholecystitispostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on KCT0012398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012398.